Royalty Pharma plc (RPRX) Adds to IPO Gains
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Royalty Pharma plc (RPRX) IPO Opens 57% Higher
June 16, 2020 12:07 PM EDTToday's IPO for Royalty Pharma plc (NASDAQ: RPRX) opened for trading at $44 after pricing 77,681,670 shares of its Class A ordinary shares at $28.
The underwriters have a 30-day option to purchase up to an additional 11,652,250 Class A ordinary shares from the company.
J.P. Morgan, Morgan Stanley, BofA Securities, Goldman Sachs & Co. LLC, Citigroup and UBS Investment Bank are acting as joint lead book-running... More
